156 related articles for article (PubMed ID: 1306098)
1. Epidemiological models of carcinogenesis: the example of bladder cancer.
Vineis P
Cancer Epidemiol Biomarkers Prev; 1992; 1(2):149-53. PubMed ID: 1306098
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of bladder cancer.
Vineis P; Martone T
Ann Ist Super Sanita; 1996; 32(1):21-7. PubMed ID: 8967722
[TBL] [Abstract][Full Text] [Related]
3. Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking.
Vineis P; Caporaso N; Tannenbaum SR; Skipper PL; Glogowski J; Bartsch H; Coda M; Talaska G; Kadlubar F
Cancer Res; 1990 May; 50(10):3002-4. PubMed ID: 2334904
[TBL] [Abstract][Full Text] [Related]
4. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
6. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens.
Bartsch H; Malaveille C; Friesen M; Kadlubar FF; Vineis P
Eur J Cancer; 1993; 29A(8):1199-207. PubMed ID: 8518034
[TBL] [Abstract][Full Text] [Related]
7. Nonsmoking-related arylamine exposure and bladder cancer risk.
Skipper PL; Tannenbaum SR; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
Badawi AF; Stern SJ; Lang NP; Kadlubar FF
Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
[TBL] [Abstract][Full Text] [Related]
10. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
[TBL] [Abstract][Full Text] [Related]
11. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
12. Effects of timing and type of tobacco in cigarette-induced bladder cancer.
Vineis P; Esteve J; Hartge P; Hoover R; Silverman DT; Terracini B
Cancer Res; 1988 Jul; 48(13):3849-52. PubMed ID: 3378220
[TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.
Marcus PM; Hayes RB; Vineis P; Garcia-Closas M; Caporaso NE; Autrup H; Branch RA; Brockmöller J; Ishizaki T; Karakaya AE; Ladero JM; Mommsen S; Okkels H; Romkes M; Roots I; Rothman N
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):461-7. PubMed ID: 10815690
[TBL] [Abstract][Full Text] [Related]
14. Tobacco smoking and risk of bladder cancer.
Boffetta P
Scand J Urol Nephrol Suppl; 2008 Sep; (218):45-54. PubMed ID: 18815916
[TBL] [Abstract][Full Text] [Related]
15. Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions.
Besaratinia A; Tommasi S
FASEB J; 2013 Jun; 27(6):2090-100. PubMed ID: 23449930
[TBL] [Abstract][Full Text] [Related]
16. Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke.
Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
IARC Sci Publ; 1988; (89):133-6. PubMed ID: 3198197
[TBL] [Abstract][Full Text] [Related]
17. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
Pavanello S; Clonfero E
G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
[TBL] [Abstract][Full Text] [Related]
18. Aromatic amines and human urinary bladder cancer: exposure sources and epidemiology.
Talaska G
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2003 May; 21(1):29-43. PubMed ID: 12826031
[TBL] [Abstract][Full Text] [Related]
19. [Acetylation phenotype as a biomarker of sensitivity to the carcinogenic effect of aromatic amines].
Indulski JA; Krajewska B; Lutz W
Med Pr; 1992; 43(5):427-35. PubMed ID: 1293477
[TBL] [Abstract][Full Text] [Related]
20. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC
Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
